Strata Skin Sciences, Inc.
SSKN
$2.89
$0.2911.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -7.36% | -8.66% | -11.29% | -7.75% | 1.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.36% | -8.66% | -11.29% | -7.75% | 1.89% |
| Cost of Revenue | -1.44% | 3.31% | 5.00% | 3.50% | 7.79% |
| Gross Profit | -11.62% | -16.77% | -22.13% | -15.19% | -1.97% |
| SG&A Expenses | -3.77% | -13.31% | -12.59% | -7.58% | -5.11% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.57% | -7.69% | -5.89% | -2.77% | 0.70% |
| Operating Income | -22.99% | 1.02% | -34.29% | -35.94% | 6.96% |
| Income Before Tax | -32.83% | -18.81% | -96.86% | -99.09% | -14.75% |
| Income Tax Expenses | -246.03% | -246.03% | -246.03% | -246.03% | 186.36% |
| Earnings from Continuing Operations | -30.39% | -16.48% | -93.18% | -95.17% | -15.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.39% | -16.48% | -93.18% | -95.17% | -15.36% |
| EBIT | -22.99% | 1.02% | -34.29% | -35.94% | 6.96% |
| EBITDA | -306.00% | -68.99% | -378.72% | -219.10% | 246.51% |
| EPS Basic | -25.88% | -15.88% | -92.10% | -93.90% | -14.63% |
| Normalized Basic EPS | -24.29% | -12.69% | -41.18% | -40.06% | 0.51% |
| EPS Diluted | -25.88% | -15.88% | -92.10% | -93.90% | -11.75% |
| Normalized Diluted EPS | -24.29% | -12.69% | -41.18% | -40.06% | 0.51% |
| Average Basic Shares Outstanding | 4.42% | 0.62% | 0.61% | 0.60% | 0.64% |
| Average Diluted Shares Outstanding | 4.42% | 0.62% | 0.61% | 0.60% | 0.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
